Literature DB >> 1622950

Nasal and orbital recurrence of conjunctival melanoma 21 years after exenteration.

A D Paridaens1, A C McCartney, R J Lavelle, J L Hungerford.   

Abstract

In our experience 5% of invasive malignant melanomas of the conjunctiva arising from areas of primary acquired melanosis with atypia spread to the ipsilateral nasal cavity and paranasal sinuses. Twenty one years after orbital exenteration for multicentric conjunctival melanoma an 82-year-old man was seen with an orbital recurrence, which had extended to the nasal cavity and paranasal sinuses through the nasolacrimal duct without invading the mucosa. This previously undescribed way of spread after the longest symptom-free interval following exenteration ever reported is illustrated.

Entities:  

Mesh:

Year:  1992        PMID: 1622950      PMCID: PMC504289          DOI: 10.1136/bjo.76.6.369

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

1.  Impression cytology of conjunctival melanosis and melanoma.

Authors:  A D Paridaens; A C McCartney; O M Curling; C J Lyons; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

2.  Tear cytology in conjunctival melanoma.

Authors:  J S Weiss; P Perusse; F Reale
Journal:  Am J Ophthalmol       Date:  1991-05-15       Impact factor: 5.258

3.  Postenucleation orbital radiotherapy for the treatment of malignant melanoma of the choroid with extrascleral extension.

Authors:  P G Hykin; A C McCartney; P N Plowman; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1990-01       Impact factor: 4.638

4.  Malignant melanoma of the nasal cavity and paranasal sinuses.

Authors:  V Lund
Journal:  J Laryngol Otol       Date:  1982-04       Impact factor: 1.469

5.  Malignant melanomas of the conjunctiva, nasal cavity, and paranasal sinuses.

Authors:  D M Robertson; J L Hungerford; A McCartney
Journal:  Am J Ophthalmol       Date:  1989-10-15       Impact factor: 5.258

  5 in total
  8 in total

1.  Sinonasal melanoma arising from conjunctival primary acquired melanosis.

Authors:  Mark Shehata; Dan Gombos; John Bishop; Mark Edwin Zafereo
Journal:  BMJ Case Rep       Date:  2015-02-18

2.  Management of conjunctival malignant melanoma: a review and update.

Authors:  James R Wong; Afshan A Nanji; Anat Galor; Carol L Karp
Journal:  Expert Rev Ophthalmol       Date:  2014-06

Review 3.  Advances in the management of conjunctival melanoma.

Authors:  Gargi K Vora; Hakan Demirci; Brian Marr; Prithvi Mruthyunjaya
Journal:  Surv Ophthalmol       Date:  2016-06-16       Impact factor: 6.048

4.  Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases.

Authors:  A D Paridaens; D C Minassian; A C McCartney; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

5.  Orbital exenteration in 95 cases of primary conjunctival malignant melanoma.

Authors:  A D Paridaens; A C McCartney; D C Minassian; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

6.  Two Late Recurrences of Conjunctival Melanoma.

Authors:  Niels J Brouwer; Stijn W Genders; Marina Marinkovic; Sjoerd G van Duinen; Martine J Jager; Gré P M Luyten
Journal:  Ocul Oncol Pathol       Date:  2018-12-12

7.  Possible dissemination of conjunctival melanoma along tear flow path.

Authors:  Toshinobu Kubota; Tomonori Kawasaki
Journal:  Am J Ophthalmol Case Rep       Date:  2018-02-23

Review 8.  Update on conjunctival pathology.

Authors:  Hardeep Singh Mudhar
Journal:  Indian J Ophthalmol       Date:  2017-09       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.